相关实验视频
Updated: Jun 7, 2025

08:35
Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
8.3K
克拉斯在调节IDO1表达方面起着负面作用
Xiandong Peng1, Eunji Lee1, Jialu Liang1
1Division of Environmental Medicine, Department of Medicine, Grossman School of Medicine, New York University, 341 East 25th Street, New York, NY 10010, USA.
Translational oncology
|November 17, 2024
概括
拉斯信号消极地调节了Indoleamine 2,3-dioxygenase-1 (IDO1) 的表达,同时促进了KRas突变癌症中编程细胞死亡蛋白1联体1 (PD-L1) 的表达. 抑制KRasG12C会增加IDO1,这表明KRas和IDO1联合向癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 拉斯蛋白质是参与细胞过程的关键信号媒介,突变与癌症和炎症疾病有关.
- 免疫检查点蛋白 (PD-1/PD-L1) 和IDO1是瘤免疫逃避中的关键参与者.
- 克拉斯在调节IDO1表达中的作用尚不清楚,与其已知对PD-L1.1的影响不同.
研究的目的:
- 研究KRas突变癌症中IDO1和PD-L1的差异调节.
- 阐明KRas信号对IDO1表达的影响.
- 探索同时针对KRas和IDO1的治疗潜力.
主要方法:
- 在KRas突变癌细胞系和患者样本中分析IDO1和PD-L1表达.
- 用特定抑制剂ARS-1620治疗KRasG12C-突变细胞.
- 对干扰素- (IFN-γ) 诱导IDO1表达在活性KRas.存在的情况下的研究.
- 评估MAPK途径对KRas抑制诱导的IDO1表达的参与.
主要成果:
- 在KRas突变癌症中,IDO1和PD-L1的调节不同.
- 通过ARS-1620抑制KRasG12C增加了IDO1的表达,与H358细胞中的PD-L1水平相反相关.
- 在具有KRas突变的肺和胰腺管腺癌患者中,IDO1的表达减少.
- 构成性活跃的KRas减弱了IFN-γ诱导的IDO1表达.
- 克拉斯抑制诱导的IDO1表达独立于MAPK通路发生.
结论:
- 克拉斯信号负面调节IDO1表达,正面调节PD-L1表达.
- 抑制KRas可以恢复IDO1的表达,这表明一种潜在的治疗策略.
- 同时准KRas和IDO1可能会提高治疗效率,并在KRas突变癌症中克服对免疫检查点阻塞的抵抗力.
更多相关视频
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Regulation of Expression at Multiple Steps
873
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
873

